The Management of Retinopathy of Prematurity

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.3, Iss.4, 2001-01, pp. : 263-272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retinopathy of Prematurity: Molecular Pathology and Therapeutic Strategies

By Mechoulam H. Pierce E.A.

American Journal of PharmacoGenomics, Vol. 3, Iss. 4, 2003-01 ,pp. : 261-277

Adis International

Access to resources Recommend Favorite

The Association between Serum Homocysteine Levels and Retinopathy of Prematurity

By Sarici AM Yetik H Akar S Arvas S

The Journal of International Medical Research, Vol. 40, Iss. 5, 2012-09 ,pp. : 1912-1918

Field House Publishing

Access to resources Recommend Favorite

Bevacizumab: Retinal vessel sheathing in an infant with retinopathy of prematurity: case report

Reactions Weekly, Vol. 1, Iss. 1337, 2011-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Heart failure therapies: First report of retinopathy of prematurity in neonates following in utero exposure: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1252, 2009-01 ,pp. : 25-26

Adis International

Access to resources Recommend Favorite

The Efficacy of Omega-3 Supplement on Prevention of Retinopathy of Prematurity in Premature Infants: A Randomized Double-blinded Controlled trial

Current Pharmaceutical Design, Vol. 24, Iss. 17, 2018-05 ,pp. : 1845-1848

Bentham Science Publishers

Access to resources Recommend Favorite